In 2014, the WHO estimated that there were 1.9 billion overweight and 600 million obese people worldwide [1], representing 39% of the global population [1]
Experimental models of anoxia/reoxygenation injury demonstrated that larazotide preserves epithelial barrier integrity by maintaining transepithelial electrical resistance and preventing the disassembly of tight junction components such as ZO-1, occludin, and claudins
Possible biological benefits under investigation include: Reduced energy intake Altered satiety signaling Modulation of body weight-related outcomes How does Cagrilintide (10mg) work in research studies
A suggested rate of weight loss is 0.5 2 pounds/week (Schweitzer 2026)
It also provides a notable amount of calcium, which may be a bonus if you arent getting enough
Standard cagrilintide dosing follows a 12-week titration from 0.6mg to 2.4mg weekly (0.6mg weeks 1-4, 1.2mg weeks 5-8, 1.8mg weeks 9-12, 2.4mg week 13+)